Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunex -- Ignore unavailable to you. Want to Upgrade?

To: D.Austin who wrote (488)	3/22/2001 5:43:43 PM
From: LemurHouse	Read Replies (2) \| Respond to of 656

Yeah, its down to the Enbrel story at this point, but that's still a pretty good story. Next year's earnings will not be negatively affected, but this will make the P/E contract obviously. How big is the market for Psoriatic Arthritis I wonder? Trying to get into the conference call now but they seem to be having trouble setting it up. PS: I think the main question will be what kind of multiple the market is willing to assign for Enbrel going forward for the next couple of years. Still a huge market.